Elite in Small Cell Lung Cancer (SCLC)

Dr. Abraham J. Wu

Radiation Oncology
Memorial Sloan Kettering Cancer Center At Basking Ridge New Jersey
136 Mountain View Blvd, 
Basking Ridge, NJ 
Offers Telehealth
Elite in Small Cell Lung Cancer (SCLC)
Memorial Sloan Kettering Cancer Center At Basking Ridge New Jersey
136 Mountain View Blvd, 
Basking Ridge, NJ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Abraham Wu is a Radiation Oncologist in Basking Ridge, New Jersey. Dr. Wu is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Pancreaticoduodenectomy, and Lymphadenectomy.

His clinical research consists of co-authoring 186 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 7 articles and participated in 1 clinical trial in the study of Small Cell Lung Cancer (SCLC).

Specialties
Radiation Oncology
Licenses
Radiology in NY
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

MEMORIAL SLOAN KETTERING CANCER CENTER AT BASKING RIDGE NEW JERSEY
136 Mountain View Blvd, Basking Ridge, NJ 07920
Other Locations
MEMORIAL RADIATION ONCOLOGY GROUP
650 Commack Rd, Commack, NY 11725
MSK MONMOUTH
480 Red Hill Rd, Middletown, NJ 07748
MEMORIAL RADIATION ONCOLOGY GROUP
1101 Hempstead Tpke, Uniondale, NY 11553
MEMORIAL RADIATION ONCOLOGY GROUP
500 Westchester Ave, West Harrison, NY 10604
MSK BERGEN
225 Summit Ave, Montvale, NJ 07645
MEMORIAL RADIATION ONCOLOGY GROUP
1275 York Ave, New York, NY 10065

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
Enrollment Status: Completed
Publish Date: October 08, 2025
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Capecitabine, Chemotherapy, Erlotinib hydrochloride, Fluorouracil, Gemcitabine hydrochloride
Study Phase: Phase 3
Phase III Randomized Trial Comparing Overall Survival After Photon Versus Proton Chemoradiotherapy for Inoperable Stage II-IIIB NSCLC
Phase III Randomized Trial Comparing Overall Survival After Photon Versus Proton Chemoradiotherapy for Inoperable Stage II-IIIB NSCLC
Enrollment Status: Active_not_recruiting
Publish Date: December 18, 2024
Intervention Type: Other, Drug, Biological, Radiation
Study Drugs: Carboplatin, Cisplatin, Durvalumab, Etoposide, Paclitaxel, Pemetrexed Disodium
Study Phase: Phase 3
A Phase I, Dose Escalation Trial of Endoluminal High Dose Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management
A Phase I, Dose Escalation Trial of Endoluminal High Dose Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management
Enrollment Status: Completed
Publish Date: November 01, 2024
Intervention Type: Radiation, Drug, Behavioral
Study Drug: Concurrent chemotherapy
Study Phase: Phase 1
A Pilot Feasibility Trial of Unidirectional Low Dose Rate Brachytherapy for Patients With Abdominal and Pelvic Malignancy Undergoing Surgical Resection Requiring Intraoperative Radiation Therapy
A Pilot Feasibility Trial of Unidirectional Low Dose Rate Brachytherapy for Patients With Abdominal and Pelvic Malignancy Undergoing Surgical Resection Requiring Intraoperative Radiation Therapy
Enrollment Status: Completed
Publish Date: October 21, 2024
Intervention Type: Device, Radiation, Procedure
Study Phase: Phase 1
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 17, 2024
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
View 4 Less Clinical Trials

186 Total Publications

Hippocampal Avoidance During Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer: Randomized Phase II/III Trial NRG-CC003.
Hippocampal Avoidance During Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer: Randomized Phase II/III Trial NRG-CC003.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 11, 2025
Similar Doctors
Andreas Rimner
Elite in Small Cell Lung Cancer (SCLC)
Dr. Andreas Rimner
Radiation Oncology
Elite in Small Cell Lung Cancer (SCLC)
Dr. Andreas Rimner
Radiation Oncology
1275 York Ave, 
New York, NY 
 (34.0 miles away)
212-639-6829
Languages Spoken:
English

Andreas Rimner is a Radiation Oncologist in New York, New York. Dr. Rimner is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Lung Cancer, Mesothelioma, Non-Small Cell Lung Cancer (NSCLC), Tissue Biopsy, and Thymectomy.

Elite in Small Cell Lung Cancer (SCLC)
Dr. Salma K. Jabbour
Radiation Oncology
Elite in Small Cell Lung Cancer (SCLC)
Dr. Salma K. Jabbour
Radiation Oncology

Rutgers Health-Rwj Scleroderma Program

195 Little Albany St, 
New Brunswick, NJ 
 (12.2 miles away)
732-253-3939
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Salma Jabbour is a Radiation Oncologist in New Brunswick, New Jersey. Dr. Jabbour is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). Her top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreaticoduodenectomy, and Liver Embolization. Dr. Jabbour is currently accepting new patients.

Daniel R. Gomez
Elite in Small Cell Lung Cancer (SCLC)
Dr. Daniel R. Gomez
Radiation Oncology
Elite in Small Cell Lung Cancer (SCLC)
Dr. Daniel R. Gomez
Radiation Oncology

Msk Bergen

225 Summit Ave, 
Montvale, NJ 
 (39.4 miles away)
908-542-3336
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Daniel Gomez is a Radiation Oncologist in Montvale, New Jersey. Dr. Gomez is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Mesothelioma.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wu's expertise for a condition
ConditionClose
View All 10 Distinguished Conditions
View All 53 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile